Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$164,137,735
+$1,473,476 QoQ
Shares Held
973,880
-15.1% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 768 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,137,735 | 973,880 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $162,664,259 | 1,146,896 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $122,278,270 | 972,856 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $110,580,202 | 999,821 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $44,402,767 | 325,295 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $40,449,594 | 351,064 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $61,891,613 | 449,565 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $58,645,790 | 425,216 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $35,730,940 | 271,182 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $8,989,312 | 79,905 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $5,123,036 | 54,327 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $80,511,400 | 795,410 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $111,785,687 | 935,915 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $92,792,809 | 873,673 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $83,339,746 | 854,942 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $77,911,781 | 831,059 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $65,445,990 | 768,416 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $73,315,426 | 764,419 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $71,355,218 | 733,202 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $66,674,794 | 685,602 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $67,804,481 | 707,402 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $71,095,992 | 739,351 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $91,811,222 | 752,551 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $68,446,769 | 790,835 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||